CD8A and neoplasm: Interestingly, the combined therapy of c-di-GMP and IRE was able to significantly increase the percentage of infiltrating activated IFN-γ and TNF-α-producing CD8+ T cells, suggesting that this combination therapy favors the activation of an antitumor immune response able to control tumor growth more efficiently.